Annual ROE
-312.38%
-147.06%-88.95%
December 31, 2023
Summary
- As of March 10, 2025, ACXP annual return on equity is -312.38%, with the most recent change of -147.06% (-88.95%) on December 31, 2023.
- During the last 3 years, ACXP annual ROE has fallen by -142.11% (-83.46%).
- ACXP annual ROE is now -204.11% below its all-time high of -102.72%, reached on December 31, 2021.
Performance
ACXP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-392.34%
-21.14%-5.70%
September 30, 2024
Summary
- As of March 10, 2025, ACXP quarterly return on equity is -392.34%, with the most recent change of -21.14% (-5.70%) on September 30, 2024.
- Over the past year, ACXP quarterly ROE has stayed the same.
- ACXP quarterly ROE is now -272.10% below its all-time high of -105.44%, reached on March 31, 2022.
Performance
ACXP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ACXP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -89.0% | 0.0% |
| 3 y3 years | -83.5% | 0.0% |
| 5 y5 years | +56.8% | 0.0% |
ACXP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -204.1% | at low | -272.1% | at low |
| 5 y | 5-year | -204.1% | +56.8% | -272.1% | at low |
| alltime | all time | -204.1% | +56.8% | -272.1% | at low |
Acurx Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -392.34%(+5.7%) |
| Jun 2024 | - | -371.20%(+20.3%) |
| Mar 2024 | - | -308.46%(+6.5%) |
| Dec 2023 | -312.38%(+89.0%) | -289.68%(+29.6%) |
| Sep 2023 | - | -223.44%(+21.5%) |
| Jun 2023 | - | -183.88%(+16.3%) |
| Mar 2023 | - | -158.15%(+19.5%) |
| Dec 2022 | -165.32% | -132.33%(+20.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -110.06%(+1.1%) |
| Jun 2022 | - | -108.83%(+3.2%) |
| Mar 2022 | - | -105.44%(-7.6%) |
| Dec 2021 | -102.72%(-39.7%) | -114.12%(-11.0%) |
| Sep 2021 | - | -128.26%(+12.2%) |
| Jun 2021 | - | -114.32%(-38.3%) |
| Mar 2021 | - | -185.40%(+8.9%) |
| Dec 2020 | -170.27%(-76.5%) | -170.27% |
| Dec 2019 | -723.42% | - |
FAQ
- What is Acurx Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals annual ROE year-on-year change?
- What is Acurx Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals quarterly ROE year-on-year change?
What is Acurx Pharmaceuticals annual return on equity?
The current annual ROE of ACXP is -312.38%
What is the all time high annual ROE for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high annual return on equity is -102.72%
What is Acurx Pharmaceuticals annual ROE year-on-year change?
Over the past year, ACXP annual return on equity has changed by -147.06% (-88.95%)
What is Acurx Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ACXP is -392.34%
What is the all time high quarterly ROE for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high quarterly return on equity is -105.44%
What is Acurx Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ACXP quarterly return on equity has changed by 0.00% (0.00%)